Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
759 | 3100 | 35.5 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
112 | 3 | CERVICAL CANCER//HUMAN PAPILLOMAVIRUS//GYNECOLOGIC ONCOLOGY | 70812 |
32 | 2 | HUMAN PAPILLOMAVIRUS//HPV//CERVICAL CANCER | 32910 |
759 | 1 | HPV VACCINE//HPV VACCINATION//HUMAN PAPILLOMAVIRUS VACCINE | 3100 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HPV VACCINE | authKW | 2571397 | 12% | 71% | 366 |
2 | HPV VACCINATION | authKW | 1086606 | 5% | 69% | 160 |
3 | HUMAN PAPILLOMAVIRUS VACCINE | authKW | 943720 | 4% | 70% | 136 |
4 | HUMAN PAPILLOMAVIRUS | authKW | 805753 | 24% | 11% | 747 |
5 | PAPILLOMAVIRUS VACCINES | authKW | 567783 | 3% | 72% | 80 |
6 | HPV | authKW | 517792 | 15% | 12% | 453 |
7 | GENITAL WARTS | authKW | 369930 | 4% | 34% | 110 |
8 | CERVICAL CANCER | authKW | 305459 | 18% | 6% | 553 |
9 | HUMAN PAPILLOMAVIRUS VACCINATION | authKW | 207044 | 1% | 73% | 29 |
10 | GARDASIL | authKW | 201345 | 1% | 66% | 31 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Public, Environmental & Occupational Health | 14754 | 29% | 0% | 890 |
2 | Immunology | 7766 | 25% | 0% | 775 |
3 | Medicine, Research & Experimental | 5178 | 16% | 0% | 498 |
4 | Infectious Diseases | 4517 | 12% | 0% | 371 |
5 | Obstetrics & Gynecology | 3163 | 10% | 0% | 320 |
6 | Pediatrics | 2375 | 10% | 0% | 322 |
7 | Oncology | 1750 | 14% | 0% | 437 |
8 | Women’s Studies | 1388 | 2% | 0% | 65 |
9 | Medicine, General & Internal | 1309 | 11% | 0% | 340 |
10 | Health Policy & Services | 1250 | 4% | 0% | 110 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HPV VACCINAT PROGRAM REGISTER | 110954 | 0% | 87% | 13 |
2 | EPIDEMIOL HIV STD UNIT | 94539 | 0% | 80% | 12 |
3 | DIAGNOST TREATMENT SEXUALLY TRANSMITTED DIS | 91661 | 0% | 85% | 11 |
4 | FAMILY MED OBSTET GYNECOL | 88628 | 0% | 75% | 12 |
5 | IMMUNIZAT SERV | 74160 | 2% | 15% | 51 |
6 | STIFTUNG JULIUSSPITAL | 70339 | 0% | 71% | 10 |
7 | ADOLESCENT BEHAV HLTH | 62251 | 0% | 45% | 14 |
8 | VACCINAT | 61472 | 1% | 39% | 16 |
9 | LOUISE GRANOFSKY PSYCHOSOCIAL ONCOL PROGRAM | 57377 | 0% | 45% | 13 |
10 | STD PREVENT | 55208 | 2% | 8% | 67 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VACCINE | 98549 | 14% | 2% | 425 |
2 | HUMAN VACCINES & IMMUNOTHERAPEUTICS | 66715 | 3% | 6% | 107 |
3 | JOURNAL OF ADOLESCENT HEALTH | 26783 | 4% | 2% | 110 |
4 | SEXUAL HEALTH | 18789 | 1% | 5% | 38 |
5 | JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY | 15902 | 1% | 5% | 34 |
6 | HUMAN VACCINES | 12583 | 1% | 5% | 26 |
7 | JOURNAL OF COMMUNITY HEALTH | 11552 | 1% | 3% | 43 |
8 | JOURNAL OF LOWER GENITAL TRACT DISEASE | 10568 | 1% | 4% | 26 |
9 | SEXUALLY TRANSMITTED DISEASES | 9426 | 2% | 2% | 60 |
10 | ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | 7322 | 2% | 1% | 65 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HPV VACCINE | 2571397 | 12% | 71% | 366 | Search HPV+VACCINE | Search HPV+VACCINE |
2 | HPV VACCINATION | 1086606 | 5% | 69% | 160 | Search HPV+VACCINATION | Search HPV+VACCINATION |
3 | HUMAN PAPILLOMAVIRUS VACCINE | 943720 | 4% | 70% | 136 | Search HUMAN+PAPILLOMAVIRUS+VACCINE | Search HUMAN+PAPILLOMAVIRUS+VACCINE |
4 | HUMAN PAPILLOMAVIRUS | 805753 | 24% | 11% | 747 | Search HUMAN+PAPILLOMAVIRUS | Search HUMAN+PAPILLOMAVIRUS |
5 | PAPILLOMAVIRUS VACCINES | 567783 | 3% | 72% | 80 | Search PAPILLOMAVIRUS+VACCINES | Search PAPILLOMAVIRUS+VACCINES |
6 | HPV | 517792 | 15% | 12% | 453 | Search HPV | Search HPV |
7 | GENITAL WARTS | 369930 | 4% | 34% | 110 | Search GENITAL+WARTS | Search GENITAL+WARTS |
8 | CERVICAL CANCER | 305459 | 18% | 6% | 553 | Search CERVICAL+CANCER | Search CERVICAL+CANCER |
9 | HUMAN PAPILLOMAVIRUS VACCINATION | 207044 | 1% | 73% | 29 | Search HUMAN+PAPILLOMAVIRUS+VACCINATION | Search HUMAN+PAPILLOMAVIRUS+VACCINATION |
10 | GARDASIL | 201345 | 1% | 66% | 31 | Search GARDASIL | Search GARDASIL |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MCCORMACK, PL , (2014) QUADRIVALENT HUMAN PAPILLOMAVIRUS (TYPES 6, 11, 16, 18) RECOMBINANT VACCINE (GARDASIL((R))): A REVIEW OF ITS USE IN THE PREVENTION OF PREMALIGNANT ANOGENITAL LESIONS, CERVICAL AND ANAL CANCERS, AND GENITAL WARTS.DRUGS. VOL. 74. ISSUE 11. P. 1253 -1283 | 119 | 89% | 11 |
2 | HOLMAN, DM , BENARD, V , ROLAND, KB , WATSON, M , LIDDON, N , STOKLEY, S , (2014) BARRIERS TO HUMAN PAPILLOMAVIRUS VACCINATION AMONG US ADOLESCENTS A SYSTEMATIC REVIEW OF THE LITERATURE.JAMA PEDIATRICS. VOL. 168. ISSUE 1. P. 76 -82 | 64 | 93% | 127 |
3 | MARKOWITZ, LE , DUNNE, EE , SARAIYA, M , CHESSON, HW , CURTIS, CR , GEE, J , BOCCHINI, JA , UNGER, ER , (2014) HUMAN PAPILLOMAVIRUS VACCINATION RECOMMENDATIONS OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP).MMWR RECOMMENDATIONS AND REPORTS. VOL. 63. ISSUE 5. P. 1 -30 | 93 | 55% | 140 |
4 | HOFSTETTER, AM , ROSENTHAL, SL , (2014) FACTORS IMPACTING HPV VACCINATION: LESSONS FOR HEALTH CARE PROFESSIONALS.EXPERT REVIEW OF VACCINES. VOL. 13. ISSUE 8. P. 1013 -1026 | 111 | 80% | 11 |
5 | HERRERO, R , GONZALEZ, P , MARKOWITZ, LE , (2015) PRESENT STATUS OF HUMAN PAPILLOMAVIRUS VACCINE DEVELOPMENT AND IMPLEMENTATION.LANCET ONCOLOGY. VOL. 16. ISSUE 5. P. E206 -E216 | 72 | 88% | 29 |
6 | GILKEY, MB , MCREE, AL , (2016) PROVIDER COMMUNICATION ABOUT HPV VACCINATION: A SYSTEMATIC REVIEW.HUMAN VACCINES & IMMUNOTHERAPEUTICS. VOL. 12. ISSUE 6. P. 1454 -1468 | 85 | 92% | 1 |
7 | JOURA, EA , GIULIANO, AR , IVERSEN, OE , BOUCHARD, C , MAO, C , MEHLSEN, J , MOREIRA, ED , NGAN, Y , PETERSEN, LK , LAZCANO-PONCE, E , ET AL (2015) A 9-VALENT HPV VACCINE AGAINST INFECTION AND INTRAEPITHELIAL NEOPLASIA IN WOMEN.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 372. ISSUE 8. P. 711 -723 | 34 | 79% | 183 |
8 | VALENTINO, K , PORONSKY, CB , (2016) HUMAN PAPILLOMAVIRUS INFECTION AND VACCINATION.JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES. VOL. 31. ISSUE 2. P. E155 -E166 | 67 | 85% | 3 |
9 | HENDRY, M , LEWIS, R , CLEMENTS, A , DAMERY, S , WILKINSON, C , (2013) "HPV? NEVER HEARD OF IT!": A SYSTEMATIC REVIEW OF GIRLS' AND PARENTS' INFORMATION NEEDS, VIEWS AND PREFERENCES ABOUT HUMAN PAPILLOMAVIRUS VACCINATION.VACCINE. VOL. 31. ISSUE 45. P. 5152-5167 | 69 | 90% | 23 |
10 | KESSELS, SJM , MARSHALL, HS , WATSON, M , BRAUNACK-MAYER, AJ , REUZEL, R , TOOHER, RL , (2012) FACTORS ASSOCIATED WITH HPV VACCINE UPTAKE IN TEENAGE GIRLS: A SYSTEMATIC REVIEW.VACCINE. VOL. 30. ISSUE 24. P. 3546-3556 | 48 | 92% | 127 |
Classes with closest relation at Level 1 |